Economic evaluation guidelines in Latin America: a current snapshot

被引:3
作者
Augustovski, Federico [1 ,2 ,3 ]
Ulises Garay, Osvaldo [1 ]
Pichon-Riviere, Andres [1 ,3 ]
Rubinstein, Adolfo [1 ,2 ,3 ]
Caporale, Joaquin E. [1 ]
机构
[1] Inst Clin Effectiveness & Hlth Policy, IECS, Buenos Aires, DF, Argentina
[2] Hosp Italiano Buenos Aires, Family & Community Med Div, Buenos Aires, DF, Argentina
[3] Univ Buenos Aires, Sch Publ Hlth, Buenos Aires, DF, Argentina
关键词
economic evaluation of health technologies; guidelines; Latin America; HEALTH TECHNOLOGY-ASSESSMENT; RESOURCE-ALLOCATION; COST-EFFECTIVENESS; PRINCIPLES;
D O I
10.1586/ERP.10.56
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Economic evaluation guidelines are widespread in developed countries with fourth hurdle systems but as of yet not in Latin America. In the present article, a systematic search was conducted in order to retrieve regional guidelines in PubMed, Latin American and Caribbean Health Sciences Literature (LILACS) and the gray literature. Four national guidelines were found: Brazil, Colombia, Cuba and Mexico. We report a thorough review of these documents, as well as a comparison among them. We conclude that, despite some differences found, they are broadly similar, and are broadly in accordance with international documents. The existence of these documents, together with other experiences in the region that explicitly use economic evaluation information for health decision making clearly shows that this global tendency is gaining momentum in Latin America, although there is still a long way to go. In the near future we will be able to see if these documents were successfully used and applied for transparent and evidence-based decision making.
引用
收藏
页码:525 / 537
页数:13
相关论文
共 28 条
  • [21] Principles of good practice for budget impact analysis: Report of the ISPOR task force on good research practices - budget impact analysis
    Mauskopf, Josephine A.
    Sullivan, Sean D.
    Annemans, Lieven
    Caro, Jaime
    Mullins, C. Daniel
    Nuijten, Mark
    Orlewska, Ewa
    Watkins, John
    Trueman, Paul
    [J]. VALUE IN HEALTH, 2007, 10 (05) : 336 - 347
  • [22] Where are the economic guidelines coming from?
    McGuire, A
    Morris, S
    Raikou, M
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2000, 16 (04) : 976 - 986
  • [23] Neto G, 2010, AVALIACAO TECNOLOGIA, P506
  • [24] Office of Technology Assessment Advisory Committee, 1976, DEV MED TECHN OPP AS
  • [25] Pichon-Riviere A, 2009, 6 HTAI ANN M PAR PAN
  • [26] Rubinstein A, 2008, DEFINITION COVERAGE
  • [27] Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle
    Taylor, RS
    Drummond, MF
    Salkeld, G
    Sullivan, SD
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2004, 329 (7472): : 972 - 975
  • [28] Cost and cost-effectiveness guidelines: which ones to use?
    Walker, D
    [J]. HEALTH POLICY AND PLANNING, 2001, 16 (01) : 113 - 121